Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence L Rudel

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Obesity (Silver Spring, Md.)|July 20, 2007
Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeysKylie Kavanagh, Kate L Jones, Janet Sawyer, et al.
Journal of Lipid Research|June 7, 2012
ACAT2 and ABCG5/G8 are both required for efficient cholesterol absorption in mice: evidence from thoracic lymph duct cannulationTam M Nguyen, Janet K Sawyer, Kathryn L Kelley, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2003
Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient miceEmily L Willner, Bryan Tow, Kimberly K Buhman, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 13, 2012
Cholesteryl esters associated with acyl-CoA:cholesterol acyltransferase predict coronary artery disease in patients with symptoms of acute coronary syndromeChadwick D Miller, Michael J Thomas, Brian Hiestand, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2013
Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 1Masaki Ohtawa, Hiroyuki Yamazaki, Satoshi Ohte, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2013
Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3Masaki Ohtawa, Hiroyuki Yamazaki, Satoshi Ohte, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2011
Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemiaTaichi Ohshiro, Daisuke Matsuda, Kent Sakai, et al.
Nutrition Research (New York, N.Y.)|July 24, 2010
Neonatal and fetal exposure to trans-fatty acids retards early growth and adiposity while adversely affecting glucose in miceKylie Kavanagh, Soraya Sajadian, Kurt A Jenkins, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2015
PRD125, a potent and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient miceAdam M Lopez, Jen-Chieh Chuang, Kenneth S Posey, et al.
Journal of Lipid Research|June 28, 2013
LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosisJohn T Melchior, Janet K Sawyer, Kathryn L Kelley, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Obesity (Silver Spring, Md.)|July 20, 2007
Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeysKylie Kavanagh, Kate L Jones, Janet Sawyer, et al.
Journal of Lipid Research|June 7, 2012
ACAT2 and ABCG5/G8 are both required for efficient cholesterol absorption in mice: evidence from thoracic lymph duct cannulationTam M Nguyen, Janet K Sawyer, Kathryn L Kelley, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2003
Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient miceEmily L Willner, Bryan Tow, Kimberly K Buhman, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|June 13, 2012
Cholesteryl esters associated with acyl-CoA:cholesterol acyltransferase predict coronary artery disease in patients with symptoms of acute coronary syndromeChadwick D Miller, Michael J Thomas, Brian Hiestand, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2013
Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 1Masaki Ohtawa, Hiroyuki Yamazaki, Satoshi Ohte, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2013
Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3Masaki Ohtawa, Hiroyuki Yamazaki, Satoshi Ohte, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2011
Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemiaTaichi Ohshiro, Daisuke Matsuda, Kent Sakai, et al.
Nutrition Research (New York, N.Y.)|July 24, 2010
Neonatal and fetal exposure to trans-fatty acids retards early growth and adiposity while adversely affecting glucose in miceKylie Kavanagh, Soraya Sajadian, Kurt A Jenkins, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2015
PRD125, a potent and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase-deficient miceAdam M Lopez, Jen-Chieh Chuang, Kenneth S Posey, et al.
Journal of Lipid Research|June 28, 2013
LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosisJohn T Melchior, Janet K Sawyer, Kathryn L Kelley, et al.
Pageof 10